既往、同时或后续膀胱癌对上尿路尿路上皮癌根治性肾输尿管切除术后预后的影响
回顾性收集1995至2009年2668例接受根治性肾输尿管切除术的非转移性上尿路尿路上皮癌患者数据,评估膀胱癌对总死亡率的影响及后续膀胱癌的预测因素。既往或同时膀胱癌患者总生存期显著短于无此情况者(HR 1.29,95%CI 1.09-1.53,p=0.0026)。无既往或同时膀胱癌的2037例中683例(33.5%)术后出现后续膀胱癌;pT0-2患者中后续膀胱癌者总生存期显著更短(HR 1.81,95%CI 1.23-2.67,p=0.0025),pT3-4患者中无此关联。
要点
- 既往或同时膀胱癌患者总生存期显著短于无此情况者(HR 1.29)。
- 无既往或同时膀胱癌者中33.5%术后出现后续膀胱癌。
- pT0-2患者后续膀胱癌与更短总生存期显著相关(HR 1.81)。
核心结论
- 膀胱癌与上尿路尿路上皮癌根治性肾输尿管切除术后更差的临床结局显著相关。
- 作者认为预防pT0-2上尿路尿路上皮癌患者的后续膀胱癌可能改善根治性肾输尿管切除术后的预后。
研究设计与样本
- 回顾性收集1995至2009年2668例接受根治性肾输尿管切除术的非转移性上尿路尿路上皮癌患者数据。
- 评估膀胱癌对总死亡率的影响及后续膀胱癌的预测因素。
主要发现
- 631例(23.7%)有既往或同时膀胱癌。
- 既往或同时膀胱癌患者总生存期显著短于无此情况者(HR 1.29,95%CI 1.09-1.53,p=0.0026)。
- 无既往或同时膀胱癌的2037例中683例(33.5%)术后出现后续膀胱癌。
- pT0-2患者中后续膀胱癌者总生存期显著短于无后续膀胱癌者(HR 1.81,95%CI 1.23-2.67,p=0.0025)。
- pT3-4患者中后续膀胱癌与更差总生存期无显著关联。
关键数值与推荐
- 多因素分析中后续膀胱癌的独立预测因素:术前为性别、术前尿细胞学及临床淋巴结状态;术后为性别、辅助化疗及病理淋巴结状态。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigated the impact of previous, simultaneous or subsequent bladder cancer on the clinical outcomes of upper urinary tract urothelial carcinoma. MATERIALS AND METHODS: We retrospectively collected data on 2,668 patients who underwent radical nephroureterectomy of nonmetastatic upper urinary tract urothelial carcinoma in 1995 to 2009. We evaluated the impact of bladder cancer on overall mortality and the factors predictive of subsequent bladder cancer. RESULTS: A total of 631 patients (23.7%) had previous or simultaneous bladder cancer. Patients with previous or simultaneous bladder cancer had significantly shorter overall survival than patients without previous or simultaneous bladder cancer (HR 1.29, 95% CI 1.09-1.53, p=0.0026). Of the 2,037 patients without previous or simultaneous bladder cancer 683 (33.5%) subsequently had bladder cancer after radical nephroureterectomy. Of patients with pT0-2 disease those with subsequent bladder cancer had significantly shorter overall survival than patients without subsequent bladder cancer (HR 1.81, 95% CI 1.23-2.67, p=0.0025). In patients with pT3-4 disease subsequent bladder cancer was not associated with worse overall survival. On multivariable analyses independent predictors of subsequent bladder cancer were gender, preoperative urine cytology and clinical node status in the preoperative setting, and gender, adjuvant chemotherapy and pathological node status in the postoperative setting. CONCLUSIONS: Bladder cancer was significantly associated with worse clinical outcomes after radical nephroureterectomy of upper urinary tract urothelial carcinoma. Preventing subsequent bladder cancer in patients with pT0-2 upper urinary tract urothelial carcinoma may lead to better prognosis in those who undergo radical nephroureterectomy.
引用
- Kuroiwa K, Inokuchi J, Nishiyama H, et al. Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma. J Urol. 2019. PMID: 31251717. doi:10.1097/JU.0000000000000422
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。